Vaccines Market - Trends Forecast Till 2028

Vaccines Market, by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), Route (IM, SC, ID, Oral), Patient (Pediatric, Adult), Type and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: December, 2021

Base Year Estimate: 2020

Report ID: D-PH-VM-1075

Format:  

Number of Pages: 267

Domain: Pharmaceutical

Vaccines Market – Trends Forecast Till 2028

The global vaccines market size is projected to reach USD 62 billion by 2026 at a CAGR of 8.2% from USD 45 billion in 2021 during the forecast period 2021-2028.

Vaccine is a biologically processed preparation which is used to achieve acquired immunity regarding a particular infectious disease. It can be used as both a prevention and cure depending on the nature of the causative nature of the infectious disease. Edward Jenner was the first person who came up with the term vaccine and also manufacture the first vaccine against the infectious disease small pox.

Due to the increasing number of infectious diseases along with the governmental focus on the immunization process and the efforts by the industries in the direction are some of the factors that have supported long-term expansion for Vaccines Market.

The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. But the market of vaccines has seen a boom during the pandemic owing to the viral cause of the disease.

Vaccines Market Research Report

North America is expected to be the largest market during the forecast period. Due to the high prevalence of infectious disease in the region along with the increased investment ibn the sector by both governmental and non-governmental organizations has led to the expansion of the market in the region.

Vaccines Market is segmented into Technology, type, disease indication, route of administration, patient type and geography.

On the basis of Type

  • Monovalent vaccines
  • Multivalent vaccines

On the basis of Technology

  • Conjugate vaccines
  • Inactivated and subunit vaccines
  • Live attenuated vaccines
  • Recombinant vaccines
  • Toxoid vaccines

On the basis of Disease Indication

  • Pneumococcal disease
  • DTP
  • Influenza
  • HPV
  • Meningococcal disease
  • Polio
  • Rotavirus
  • Hepatitis
  • MMR
  • Varicella
  • Herpes zoster
  • Other disease indications

On the basis of Route of Administration

  • Intramuscular and subcutaneous administration
  • Oral administration
  • Other routes of administration

On the basis of Patient Type

  • Pediatric patients
  • Adult patients

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Vaccines Market Respondents

 

Key Players

  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Johnson & Johnson
  • AstraZeneca
  • Serum Institute of India Pvt. Ltd.
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo Company, Limited
  • Panacea Biotec
  • Biological E
  • Bharat Biotech
  • Sinovac Biotech Ltd.
  • Incepta Vaccine Ltd.
  • Valneva SE
  • VBI Vaccines Inc.
  • PT Bio Farma

Recent Developments

  • In November 2021, Covaxin produced by Bharat biotech received the approval from WHO for emergency use.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Vaccines market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 45 billion

Growth Rate

CAGR of 8.2% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD million and CAGR from 2021 to 2028

Report Segmentation

Technology, type, disease indication, route of administration, patient type and geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

GlaxoSmithKline plc , Pfizer, Inc. , Sanofi Pasteur , Merck & Co., Inc. , CSL Limited (Australia), Emergent BioSolutions, Inc. , Johnson & Johnson , AstraZeneca , Serum Institute of India Pvt. Ltd. , Bavarian Nordic , Mitsubishi Tanabe Pharma Corporation , Daiichi Sankyo Company, Limited , Panacea Biotec , Biological E , Bharat Biotech , Sinovac Biotech Ltd., Incepta Vaccine Ltd. , Valneva SE , VBI Vaccines Inc. , and PT Bio Farma

Available Customization

In addition to the market data for Vaccines Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.